A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/1997
11/18/1997	US5688815 Hydroxypyridinones
11/18/1997	US5688803 Tricyclic dicarbonyl derivatives
11/18/1997	US5688796 Heterocyclic substituted benzothiophenes, compositions, and methods
11/18/1997	US5688780 Anticholesterol agents, cholesterol biosynthesis inhibition
11/18/1997	US5688760 Polypeptides having bone resorption inhibitory activity comprising PTHrP-derived sequences
11/18/1997	CA2048355C P-oxybenzoic acid derivatives, process for the preparation thereof and use thereof as drug
11/13/1997	WO1997042187A1 Oxindole derivatives
11/13/1997	WO1997042184A1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen fumarate
11/13/1997	WO1997042174A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
11/13/1997	WO1997042152A1 Vitamin d analogs and methods of preparing these compounds
11/13/1997	WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997	WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	WO1997041881A1 Morphogen treatment for chronic renal failure
11/13/1997	WO1997041880A1 Therapies for chronic renal failure
11/13/1997	WO1997041862A1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents
11/13/1997	WO1997037998A3 Neuropeptide y receptor y5 and nucleic acid sequence
11/13/1997	WO1997024116A3 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
11/13/1997	WO1996040048A3 Novel uses for thyroid hormones or thyroid hormone-like compounds
11/13/1997	CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997	CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	CA2253284A1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-¬2-(pyrrolidin-1-yl)ethoxy\|-phenyl}chromane, hyrogen fumarate
11/13/1997	CA2204704A1 Cosmetic composition with long chain unsaturated retinol fatty acid esters
11/12/1997	EP0806465A1 Antioxidant composition and method for production thereof
11/12/1997	EP0805796A1 Cell adhesion inhibitors
11/12/1997	EP0805687A1 Recombinant human alpha-fetoprotein and uses thereof
11/12/1997	EP0805682A1 Dermatological use of vitamin d derivatives
11/12/1997	CN1164409A Method for preparation of Tangniaokang medicine for curing diabetes
11/12/1997	CN1164387A Stable carotenoid emulsions suitable for parenteral administration
11/12/1997	CN1036389C Phenylacetyl deriv. of 4-amino-2,6-dimethyl phenylsulfonyl-nitro-methane or preparing process thereof
11/11/1997	US5686622 Thiazolidine derivatives, their preparation and the medicaments containing the same
11/11/1997	US5686615 Stereoselective preparation of substituted piperidines
11/11/1997	US5686475 Application of riluzole in the treatment of mitochondrial diseases
11/11/1997	US5686467 2-phenyl-3-aroylbenzothiophenes
11/11/1997	US5686435 Vitamin D amide derivatives
11/11/1997	US5686431 Methods of using low molecular weight heparins for treatment of pathological processes
11/11/1997	US5686429 Method for providing nutrition to elderly patients
11/11/1997	US5686425 Composition and method for revitalizing scar tissue
11/11/1997	US5686408 Insulin like growth factor; chronic post administration modification of glucose or insulin levels
11/06/1997	WO1997041129A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
11/06/1997	WO1997041127A1 Halo-substituted protein kinase c inhibitors
11/06/1997	WO1997041121A1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
11/06/1997	WO1997041120A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
11/06/1997	WO1997041119A1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
11/06/1997	WO1997041099A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	WO1997041098A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	WO1997041097A2 Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
11/06/1997	WO1997041090A1 Inorganic ion receptor-active compounds
11/06/1997	WO1997040855A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997	WO1997040837A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
11/06/1997	WO1997040832A1 Use of dipeptidyl peptidase iv effectors for lowering the blood glucose level in mammals
11/06/1997	WO1997040679A1 Methods for delivering compounds into a cell
11/06/1997	CA2253433A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997	CA2252869A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
11/06/1997	CA2252696A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	CA2252617A1 Methods for delivering compounds into a cell
11/05/1997	EP0805158A2 Halo-substituted protein kinase C inhibitors
11/05/1997	EP0805147A1 Novel N-substituted alpha aminoacid amides as calcium channel modulators
11/05/1997	EP0804577A2 cDNA ENCODING A BMP TYPE II RECEPTOR
11/05/1997	EP0804479A1 Method of treating diabetes mellitus using kgf
11/05/1997	EP0804469A1 Novel peptide
11/05/1997	EP0804435A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/05/1997	EP0804419A1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
11/05/1997	EP0804223A1 Hgh containing pharmaceutical compositions
11/05/1997	EP0804218A1 Product and process for regulating signal transduction pathways
11/05/1997	EP0804207A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
11/05/1997	EP0804198A1 An exercise hydration regimen to enhance exercise endurance and performance
11/05/1997	EP0804192A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
11/05/1997	EP0804189A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment
11/05/1997	EP0804187A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
11/05/1997	EP0804185A1 Arsenic medicaments for the treatment of chronic fatigue syndrome
11/05/1997	EP0804181A1 Method and composition for treating mammalian diseases caused by inflammatory response
11/05/1997	CN1164234A Pyrrolo £2,3-d\| pyrimidines and their use
11/05/1997	CN1164230A Hypolipidemic benzothiazepines
11/05/1997	CN1164226A Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
11/04/1997	US5684161 Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives
11/04/1997	US5684151 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
11/04/1997	US5684047 4-guanidinobutyramide for improving blood circulation
11/04/1997	US5684034 1H-indole-3-acetamide sPLA2 inhibitors
11/04/1997	US5684017 Antiarthritic agents, rheumatic diseases, antidiabetic agents for inhibiting interloeukins
11/04/1997	US5684014 Cycloalkano-indole and -azaindole derivatives
11/04/1997	US5684004 Antineoplastic agents, antiatherosclerotic agents, hypocholesterolemic agents
11/04/1997	US5683984 Enteral tube feeding composition with a native micellar casein protein component
11/04/1997	US5683693 Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
11/04/1997	CA2089607C Nutritional supplement for the elderly
11/03/1997	CA2204082A1 Pharmaceutical compounds
10/1997
10/30/1997	WO1997040066A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997	WO1997040017A2 Modulators of molecules with phosphotyrosine recognition units
10/30/1997	WO1997040006A2 Phosphate mimics
10/30/1997	WO1997039755A1 Oral pharmaceutical preparation containing ibandronat
10/30/1997	WO1997039749A2 Method for the prevention and treatment of cachexia and anorexia
10/30/1997	WO1997039748A1 Modulators of molecules with phosphotyrosine recognition units
10/30/1997	WO1997039641A1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
10/30/1997	DE19616486A1 Verfahren zur Senkung des Blutglukosespiegels in Säugern A method for lowering blood glucose levels in mammals
10/30/1997	CA2252778A1 Phosphate mimics
10/30/1997	CA2251714A1 Suppression of immune response via inhibition of cathepsin s
10/29/1997	EP0803576A2 Process for the production of lipstatin and tetrahydrolipstatin
10/29/1997	EP0803501A1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors
10/29/1997	EP0803249A2 Cholesterol lowering drink mix compositions
10/29/1997	EP0802910A1 Estrogen agonists/antagonists
10/29/1997	EP0802902A1 Indole derivatives useful in the treatment of osteoporosis

1 ... 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 ... 1298